Approval · Notice of Compliance 36176 · 2025
VECTIBIX: Notice of Compliance 36176
Issued October 10, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36176
- Date
- October 10, 2025
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Drug substance manufacturing process change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VECTIBIX | Not yet assigned | — |
Medicinal ingredients
- PANITUMUMAB 100 MG per 5ML
- PANITUMUMAB 400 MG per 20ML
- PANITUMUMAB 200 MG per 10ML